Ming Cui
Impact in
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
-
- Gastric Cancer Management and Outcomes
- Metastasis and carcinoma case studies
Papers in
-
- Gastric Cancer Management and Outcomes 21
- Metastasis and carcinoma case studies 4
- Prostate Cancer Diagnosis and Treatment 2
- Oncology 8
- Colorectal Cancer Surgical Treatments 6
- Co-authors
- Xiangqian Su (31 shared papers)Jiadi Xing (26 shared papers)Zhendan Yao (28 shared papers)Hong Yang (20 shared papers)Maoxing Liu (23 shared papers)Chenghai Zhang (26 shared papers)Fei Tan (22 shared papers)Kai Xu (18 shared papers)
In The Last Decade
Ming Cui
44 papers receiving 805 citations
Ming Cui's Hit Papers
Peers
Comparison fields: 5 of 54
- Gastroenterology 117
- Pulmonary and Respiratory Medicine 509
- Oncology 97
- Surgery 138
- Cancer Research 24
Countries citing papers authored by Ming Cui
This map shows the geographic impact of Ming Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Cui more than expected).
Fields of papers citing papers by Ming Cui
This network shows the impact of papers produced by Ming Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Cui. The network helps show where Ming Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial Hit paper breakdown → | 2021 | 310 |
| 2 | 2018 | 59 | |
| 3 | 2015 | 45 | |
| 4 | 2020 | 37 | |
| 5 | 2012 | 33 | |
| 6 | 2014 | 31 | |
| 7 | 2025 | 24 | |
| 8 | 2021 | 22 | |
| 9 | 2018 | 19 | |
| 10 | 2013 | 18 | |
| 11 | 2022 | 17 | |
| 12 | 2023 | 16 | |
| 13 | 2013 | 15 | |
| 14 | 2024 | 14 | |
| 15 | 2022 | 13 | |
| 16 | 2021 | 12 | |
| 17 | 2015 | 12 | |
| 18 | 2022 | 12 | |
| 19 | 2019 | 12 | |
| 20 | 2023 | 10 |
About Ming Cui
Ming Cui is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Renewable Energy, Sustainability and the Environment and Cardiology and Cardiovascular Medicine, having authored 47 papers that have together received 816 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (21 papers), Colorectal Cancer Surgical Treatments (6 papers), Metastasis and carcinoma case studies (4 papers), Phase Change Materials Research (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Solar Thermal and Photovoltaic Systems (2 papers) and Heat Transfer and Optimization (2 papers). The work is most often cited by research in Gastroenterology (117 citations), Pulmonary and Respiratory Medicine (509 citations), Oncology (97 citations), Surgery (138 citations) and Cancer Research (24 citations). Ming Cui has collaborated with scholars based in China, Ethiopia and Romania. Frequent co-authors include Xiangqian Su, Jiadi Xing, Zhendan Yao, Hong Yang, Maoxing Liu, Chenghai Zhang, Fei Tan, Kai Xu, Zaozao Wang and Beihai Jiang. Their work appears in journals such as Medical Oncology, Surgical Endoscopy, Frontiers in Oncology, The Lancet Oncology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.